Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow
Aug 23, 2012 | Posted by: roboblogger | Full story: TheStreet.com
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors.
Thank you for this interesting details about Johnson and Johnson valuation and prospective market. Check this site for more details on hip replacement related issues www.hipreplacementhub.zoomshare.com
The hip replacement success indeed depends on how a person respond to treatment. Check http://www.hipreplacementlawsuitcenter.com
We may never know nowadays what could be the fate of Johnson and Johnson after bombarded with several lawsuits for marketing defective medication and implants such as those i have read at http://www.depuyrecallnewscenter.com/lawsuits...
|US clears Johnson & Johnson hepatitis C drug||Nov 23||WARNING FDA APPROVED||1|
|DePuy ASR Hip Lawsuit Update: Federal ASR Hip L...||Jul '13||Jimmy||1|
|DePuy ASR Hip Recall: Status Conference Held in... (Jan '13)||Jul '13||Steve Austin||6|
|J&J to stop selling metal-on-metal hip replacem... (May '13)||Jul '13||Susan||2|
|New Market Report: DePuy Medical Device Company... (Jun '12)||Jul '13||Ray Lin||6|
|Lawsuits filed over recalled hip joints (Jul '11)||Jul '13||Bryan||10|
|Trial under way in LA hip joint replacement suit (Jan '13)||Jul '13||Steve Austin||6|